These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 22789538)

  • 1. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
    Bywater MJ; Poortinga G; Sanij E; Hein N; Peck A; Cullinane C; Wall M; Cluse L; Drygin D; Anderes K; Huser N; Proffitt C; Bliesath J; Haddach M; Schwaebe MK; Ryckman DM; Rice WG; Schmitt C; Lowe SW; Johnstone RW; Pearson RB; McArthur GA; Hannan RD
    Cancer Cell; 2012 Jul; 22(1):51-65. PubMed ID: 22789538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling.
    Quin J; Chan KT; Devlin JR; Cameron DP; Diesch J; Cullinane C; Ahern J; Khot A; Hein N; George AJ; Hannan KM; Poortinga G; Sheppard KE; Khanna KK; Johnstone RW; Drygin D; McArthur GA; Pearson RB; Sanij E; Hannan RD
    Oncotarget; 2016 Aug; 7(31):49800-49818. PubMed ID: 27391441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
    Calo E; Gu B; Bowen ME; Aryan F; Zalc A; Liang J; Flynn RA; Swigut T; Chang HY; Attardi LD; Wysocka J
    Nature; 2018 Feb; 554(7690):112-117. PubMed ID: 29364875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Targeting of RNA Polymerase I With the Small-Molecule CX-5461 for Prevention of Arterial Injury-Induced Neointimal Hyperplasia.
    Ye Q; Pang S; Zhang W; Guo X; Wang J; Zhang Y; Liu Y; Wu X; Jiang F
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):476-484. PubMed ID: 28062495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
    Drygin D; Lin A; Bliesath J; Ho CB; O'Brien SE; Proffitt C; Omori M; Haddach M; Schwaebe MK; Siddiqui-Jain A; Streiner N; Quin JE; Sanij E; Bywater MJ; Hannan RD; Ryckman D; Anderes K; Rice WG
    Cancer Res; 2011 Feb; 71(4):1418-30. PubMed ID: 21159662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy.
    Woods SJ; Hannan KM; Pearson RB; Hannan RD
    Biochim Biophys Acta; 2015 Jul; 1849(7):821-9. PubMed ID: 25464032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study.
    Khot A; Brajanovski N; Cameron DP; Hein N; Maclachlan KH; Sanij E; Lim J; Soong J; Link E; Blombery P; Thompson ER; Fellowes A; Sheppard KE; McArthur GA; Pearson RB; Hannan RD; Poortinga G; Harrison SJ
    Cancer Discov; 2019 Aug; 9(8):1036-1049. PubMed ID: 31092402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the nucleolus for cancer intervention.
    Quin JE; Devlin JR; Cameron D; Hannan KM; Pearson RB; Hannan RD
    Biochim Biophys Acta; 2014 Jun; 1842(6):802-16. PubMed ID: 24389329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
    Lee HC; Wang H; Baladandayuthapani V; Lin H; He J; Jones RJ; Kuiatse I; Gu D; Wang Z; Ma W; Lim J; O'Brien S; Keats J; Yang J; Davis RE; Orlowski RZ
    Br J Haematol; 2017 Apr; 177(1):80-94. PubMed ID: 28369725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 induces a survival transcriptional response after nucleolar stress.
    Liao H; Gaur A; Mauvais C; Denicourt C
    Mol Biol Cell; 2021 Oct; 32(20):ar3. PubMed ID: 34319761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis.
    Negi SS; Brown P
    Oncotarget; 2015 Jul; 6(20):18094-104. PubMed ID: 26061708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway.
    Chen H; Duo Y; Hu B; Wang Z; Zhang F; Tsai H; Zhang J; Zhou L; Wang L; Wang X; Huang L
    Oncotarget; 2016 Nov; 7(48):78747-78763. PubMed ID: 27729611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers.
    Udugama M; Sanij E; Voon HPJ; Son J; Hii L; Henson JD; Chan FL; Chang FTM; Liu Y; Pearson RB; Kalitsis P; Mann JR; Collas P; Hannan RD; Wong LH
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4737-4742. PubMed ID: 29669917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the nucleolus for cancer-specific activation of p53.
    Drygin D; O'Brien SE; Hannan RD; McArthur GA; Von Hoff DD
    Drug Discov Today; 2014 Mar; 19(3):259-65. PubMed ID: 23993916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-fibrotic effects of p53 activation induced by RNA polymerase I inhibitor in primary cardiac fibroblasts.
    Pang S; Chen Y; Dai C; Liu T; Zhang W; Wang J; Cui X; Guo X; Jiang F
    Eur J Pharmacol; 2021 Sep; 907():174303. PubMed ID: 34217709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
    Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
    Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear mitotic apparatus protein NuMA controls rDNA transcription and mediates the nucleolar stress response in a p53-independent manner.
    Jayaraman S; Chittiboyina S; Bai Y; Abad PC; Vidi PA; Stauffacher CV; Lelièvre SA
    Nucleic Acids Res; 2017 Nov; 45(20):11725-11742. PubMed ID: 28981686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 represses ribosomal gene transcription.
    Budde A; Grummt I
    Oncogene; 1999 Jan; 18(4):1119-24. PubMed ID: 10023689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.
    Hein N; Cameron DP; Hannan KM; Nguyen NN; Fong CY; Sornkom J; Wall M; Pavy M; Cullinane C; Diesch J; Devlin JR; George AJ; Sanij E; Quin J; Poortinga G; Verbrugge I; Baker A; Drygin D; Harrison SJ; Rozario JD; Powell JA; Pitson SM; Zuber J; Johnstone RW; Dawson MA; Guthridge MA; Wei A; McArthur GA; Pearson RB; Hannan RD
    Blood; 2017 May; 129(21):2882-2895. PubMed ID: 28283481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.